Ajanta Pharma Ltd
Ticker: AJANTPHARM
Decent
72/100
☆ Add to Watchlist
Investing Reference
Price
2409.70
Market Cap
30105.74
Debt/Equity
0.0125
ROE %
25.019
PB
7.9429
Promoter %
66.245
Pledge %
10.120
1Y Rev Growth %
10.465
5Y Rev Growth %
12.092
NP Margin %
19.407
NP Margin 5Y Avg %
19.354
Trading Reference
1M Return %
-7.258
6M Return %
-8.139
1Y Return %
-26.977
% Away 52W High
40.889
% Away 52W Low
3.541
Daily Volume
168959
Investment Verdict
Risky
Score 56/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 20/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Ajanta Pharma Ltd is currently trading near a key support level, with recent volume trends indicating increased buying interest. If the stock can maintain above this support, there is a favorable outlook for a potential rally towards the resistance level, supported by the 50-day EMA. However, if it breaks below the support, there could be a downside risk.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
E
Embassy Office Parks REIT
Embassy Office Parks REIT shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
N
New India Assurance Company Ltd
The stock shows moderate potential but lacks strong growth drivers and faces some risks.
View details
E
Elitecon International Ltd
Elitecon International Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
L
LIC Housing Finance Ltd
LIC Housing Finance Ltd shows potential for growth but faces challenges in profitability and valuation. Caution is advised.
View details
K
Krishna Institute of Medical Sciences Ltd
The stock shows decent potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
A
Apollo Tyres Ltd
Apollo Tyres Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
View details
I
Indraprastha Gas Ltd
Indraprastha Gas Ltd shows decent fundamentals with growth potential, but investors should be cautious of execution risks and valuation levels.
View details
I
ITI Ltd
ITI Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
G
Gujarat Gas Ltd
Gujarat Gas Ltd shows decent potential with solid growth prospects, but investors should be cautious of valuation and execution risks.
View details
G
Garden Reach Shipbuilders & Engineers Ltd
Garden Reach Shipbuilders & Engineers Ltd shows potential for growth, but faces challenges in profitability and execution risks.
View details
A
Affle 3i Ltd
Affle 3i Ltd shows potential for growth in a promising sector, but valuation concerns and execution risks warrant caution.
View details
I
ICICI Securities Ltd
ICICI Securities Ltd shows decent potential with a stable business model and growth prospects, but faces challenges in profitability and market competition.
View details
A
AIA Engineering Ltd
AIA Engineering Ltd shows potential for growth, but investors should be cautious of valuation and execution risks.
View details
N
NBCC (India) Ltd
NBCC (India) Ltd presents a risky investment due to inconsistent growth and market challenges, despite some strengths in its business model.
View details
T
Tata Technologies Ltd
Tata Technologies Ltd shows potential for growth, but investors should be cautious due to fluctuating profitability and execution risks.
View details
K
KIOCL Ltd
KIOCL Ltd shows potential for growth in a stable sector, but faces challenges in profitability and valuation metrics.
View details
Business Overview
Ajanta Pharma Ltd is a prominent Indian pharmaceutical company dedicated to developing high-quality medicines across various therapeutic segments. With a focus on both domestic and international markets, Ajanta is committed to enhancing healthcare through innovative solutions. The company caters to diverse needs, ranging from chronic diseases to acute conditions, ensuring accessibility and affordability. Ajanta's robust R&D capabilities and strong distribution network position it as a trusted partner in healthcare.
- Established player in the pharmaceutical industry
- Wide range of therapeutic products
- Strong focus on R&D and innovation
- Robust distribution network
- Commitment to quality and affordability
Investment Thesis
Ajanta Pharma Ltd stands out as a compelling investment due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. These factors position the company well for sustained growth and shareholder value creation.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services, aligning with industry trends.
- Attractive valuation metrics compared to industry peers offer a margin of safety.
- Consistent financial performance and dividend history support long-term investment.
- Strategic focus on expanding global footprint and product portfolio.
Opportunity vs Risk
Opportunities
- Strong product pipeline
- Expanding international markets
- Growing demand for generics
- R&D investment increasing
- Strategic partnerships with global firms
Risks ⚠️
- Regulatory challenges in India
- Currency fluctuations impacting exports
- Intense competition in pharma sector
- Rising raw material costs
- Market volatility affecting stock price
Peer Perspective
Ajanta Pharma Ltd trades at a discount to peers like Sun Pharma and Lupin, primarily due to concerns over margin stability. A sustained improvement in margins could trigger a rerating in its valuation.
Future Outlook
Ajanta Pharma Ltd is well-positioned for growth, driven by its robust product pipeline and expanding global presence. Successful execution of its strategic initiatives and effective cost control will be crucial to realizing its full potential.
AI FAQs for Retail Users
- Q: What does Ajanta Pharma Ltd do?A: Ajanta Pharma Ltd is a pharmaceutical company that specializes in manufacturing and marketing generic medicines.
- Q: Is Ajanta Pharma Ltd a good investment?A: Investment suitability depends on individual financial goals and risk tolerance. Research thoroughly before investing.
- Q: What are the key products of Ajanta Pharma?A: Ajanta Pharma offers a range of products including formulations in various therapeutic segments like dermatology and cardiology.
- Q: How has Ajanta Pharma performed recently?A: Recent performance can be checked through financial reports and market analysis. Past performance does not guarantee future results.
- Q: Where can I find more information about Ajanta Pharma?A: You can visit the company's official website or check financial news platforms for updates and reports.
📊 Stock Investment Checklist (100 Points)
Ajanta Pharma Ltd • Updated: 2025-09-16 19:22:03
-
10BusinessHighPharmaceutical sector is growing, but competition is intense.
-
10GrowthHighConsistent revenue growth, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is volatile.
-
8ValuationHighP/E ratio is higher than industry average, indicating overvaluation.
-
7BalanceHighModerate debt levels, but liquidity is adequate.
-
9GovernanceHighPromoter holding is strong, but some pledging exists.
-
6DriversGoodGrowth drivers are present, but execution risks remain.
-
5TechnicalsGoodMarket sentiment is mixed with low liquidity.
Final Score & Verdict
Score 72 / 100
• Decent
Ajanta Pharma shows potential for growth but faces challenges in profitability and valuation.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 70/100